Do most patients undergoing robotic radical cystectomy receive an orthotopic neobladder?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 3, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Neobladder Utilization in Robotic Cystectomy

No, most robotic cystectomy patients do not receive a neobladder—the majority receive an ileal conduit instead. The available evidence consistently demonstrates that neobladder reconstruction represents a minority of urinary diversions performed after radical cystectomy, whether robotic or open.

Evidence from Clinical Practice

The data reveals that neobladder rates are substantially lower than ileal conduit rates in real-world practice:

  • In one robotic series, only 14.8% of female patients received orthotopic neobladders out of 196 total cystectomies 1
  • A recent study showed that among 79 patients undergoing robotic cystectomy after prior prostatic intervention, only 22% (17 patients) received neobladders while 78% received ileal conduits 2
  • Multiple series report neobladder reconstruction in approximately 40-50% of carefully selected patients at high-volume centers, but this represents specialized academic institutions with particular expertise 3, 4, 5

Why Neobladders Are Less Common

Strict contraindications significantly limit neobladder candidacy:

Current guidelines explicitly state: "Do not offer an orthotopic bladder substitute diversion to patients who have an invasive tumour in the urethra or at the level of urethral dissection" 6. This is a strong recommendation that immediately excludes a substantial portion of patients.

Additional limiting factors include:

  • Patient age and comorbidities - Older patients and those with significant medical issues are often not candidates
  • Tumor location - Bladder neck involvement occurs in approximately 22% of patients, though this is not an absolute contraindication if frozen section margins are negative 1
  • Urethral involvement - Approximately 12% of women undergoing cystectomy have urethral tumor involvement 1
  • Patient preference - Many patients prefer the simplicity of an ileal conduit over the complexity of neobladder management
  • Renal function - Adequate renal function is required for neobladder reconstruction
  • Cognitive function and dexterity - Patients must be able to perform clean intermittent catheterization if needed

Gender Disparities

Women are significantly less likely to receive neobladders than men. Historical data shows that in mixed-gender series, women comprised only 14.8-29% of neobladder recipients despite representing a substantial portion of bladder cancer patients 1. This disparity has improved over time but remains significant.

Clinical Reality vs. Specialized Centers

While high-volume robotic centers may report neobladder rates of 40-60% in their series 3, 4, 7, these represent highly selected patient populations at academic institutions with particular expertise. The broader surgical community performs ileal conduits more frequently due to:

  • Shorter operative time (mean difference of approximately 50-60 minutes less for conduit) 8
  • Lower technical complexity
  • Fewer postoperative complications requiring management
  • Less demanding postoperative care requirements

Bottom Line

Ileal conduit remains the most common urinary diversion after robotic radical cystectomy. Neobladder reconstruction is reserved for carefully selected patients who meet strict oncologic criteria, have adequate organ function, possess the cognitive and physical ability to manage the neobladder, and specifically desire continent diversion despite understanding the associated risks and management requirements.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.